Adili Tsaba
Directeur Technique/Scientifique/R&D chez VESSL Therapeutics Ltd.
Profil
Adili Tsaba is currently working as the Vice President-Regulatory & Clinical Affairs at VESSL Therapeutics Ltd.
Prior to this, Ms. Tsaba completed an undergraduate degree at Technion-Israel Institute of Technology in 1996.
Ms. Tsaba also pursued graduate studies at Technion-Israel Institute of Technology.
Postes actifs de Adili Tsaba
| Sociétés | Poste | Début |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Directeur Technique/Scientifique/R&D | 01/01/2001 |
Formation de Adili Tsaba
| Technion-Israel Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
